HomeIBRX • NASDAQ
add
Immunitybio Inc
Previous close
$2.47
Day range
$2.45 - $2.54
Year range
$1.83 - $7.48
Market cap
2.33B USD
Avg Volume
7.19M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 26.42M | 2,423.88% |
Operating expense | 97.57M | -2.80% |
Net income | -92.56M | 31.22% |
Net profit margin | -350.26 | 97.27% |
Earnings per share | -0.10 | — |
EBITDA | -67.40M | 28.99% |
Effective tax rate | -0.29% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 153.66M | -29.51% |
Total assets | 402.08M | -9.51% |
Total liabilities | 971.90M | -14.87% |
Total equity | -569.82M | — |
Shares outstanding | 945.25M | — |
Price to book | -3.98 | — |
Return on assets | -50.50% | — |
Return on capital | -70.63% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -92.56M | 31.22% |
Cash from operations | -79.75M | 20.53% |
Cash from investing | -16.14M | 68.65% |
Cash from financing | 172.81M | 16.06% |
Net change in cash | 77.00M | 2,727.02% |
Free cash flow | -55.55M | 4.45% |
About
CEO
Founded
2014
Website
Employees
685